nervous: search

Banks nervous as Centro deadline looms

Centro Properties Group is expected to hold its annual investors' meeting in late November 2008. Commonwealth Bank of Australia is believed to have around $A990 million in secured exposure and $A160 million in unsecured exposure to the troubled property group, and is thought to have become increasingly nervous in recent days about Centro's ability to survive

Banks nervous as Centro deadline looms

LONG-SUFFERING shareholders of Centro Properties Group will get their day in the sun this week when the directors face the annual investors' meetings - if the group survives the next few days.

'Nervous wait' for recalled Symonds

Andrew Symonds is a great player with nothing to prove, according to Andrew Hilditch, the chairman of selectors

The Week Ahead: Nervous market awaits call from Vodafone

There has been some nervousness in the market ahead of Vodafone's interim results, which are due tomorrow. The telecoms group's shares were sold early last week on rumours that it was guiding forecasts lower.

Hauritz bounces back after nervous start

Barely two years ago, the former Australian fast bowler watched as a timid, downbeat Nathan Hauritz trudged through the gates of his Randwick-Petersham club in search of the opportunities denied him in his native Queensland.

Researchers discover a novel therapy for chronic pain by blocking an intracellular protein interaction in the central nervous system

Exporting Financing Human Resources Managing Personal Development Sales & Marketing Startup Guide Technology

Symonds looms large for Voges

WA batsman Adam Voges has admitted to feeling nervous ahead of tomorrow’s Sheffield Shield clash with Queensland at the WACA Ground.

Christmas tree season begins

Owners of Christmas tree lots say they're among nervous U.S. retailers feeling the urgency of a shopping season with only four weeks.

Damon Albarn daunted by Opera

Damon Albarn has revealed he was reluctant to write Monkey: Journey To The West because he was so nervous about composing an opera.

Beyonce denies breakdown rumours

Beyonce Knowles has spoken out about a recent magazine article in which she revealed she almost suffered a nervous breakdown.

Gene Discovery Could Help ALS Patients

(Ivanhoe Newswire) -- Scientists are one step closer to understanding how to treat and repair diseases of the nervous system, such as amyotrophic lateral sclerosis (ALS), or Lou Gehrigs disease.

Gene Discovery Could Help ALS Patients

(Ivanhoe Newswire) -- Scientists are one step closer to understanding how to treat and repair diseases of the nervous system, such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.

Sundance Film Festival May Request State Aid

Film lovers are gearing up for the Sundance Film Festival. It takes place in January, and festival organizers are nervous about festival finances. Apparently, it's hard to get corporate sponsorships in this tough year for the economy. So the film festival may ask the state of Utah for financial aid. Organizers recently met with state officials and said the film festival is good for the state's economy. An official with the Governor's Office of Economic Development responded that everyone is having a tough time right now.

Adeona Pharma gets US patent for oral Tiomolibdate Diammonium for Alzheimer's disease

Adeona Pharmaceuticals, Inc, a late-stage pharmaceutical company developing innovative drug candidates for the treatment of autoimmune and central nervous system diseases, announced the issuance of US Patent No 7,416,741 containing claims covering the use of thiomolybdates such as oral tiomolibdate diammonium (USAN name for oral tetrathiomolybdate, or TTM) for the treatment of Alzheimer's disease (AD).

The open source community has cast its vote

Things seem particularly contentious this election year, and everyone can only really agree on one thing: there’s an awful lot at stake. Are you nervous? We are too. To settle the debate, we polled over 250 random SourceForge.net and Slashdot users on a wide range of political issues…because, after all, you guys are not known for mincing your words. We figured that if anyone can get to the bottom of this, you can.

Day 14 Boat Blogs from Leg 1 Volvo Ocean Race

I cannot help feeling every time a cloud parks itself over our boat 'why us?' The wind drops, starts shifting in funny directions and then sometimes dies altogether leaving you feeling nervous that you are losing miles to all your competitors. I am sure that everyone one in the race so far has had the fair share of clouds and squalls to deal with, but it still doesn't help at the time.

Circuit City files for Chapter 11 protection

NEW YORK (Agencies): Circuit City Stores has filed for bankruptcy about a week after it said it would close 20 percent of its stores. The Richmond, Virginia-based electronics retailer has been struggling as nervous consumers spend less and credit has become tighter. It filed for bankruptcy protection on Monday. Chapter 11 protection typically allows a company to hold off creditors and operate as normal while it develops a financial reorganization plan. Circuit City says it has more than $1 billion in assets and more than $1 billion in liabilities. Courts do not require companies to provide more specific figures in filings. The company says it anticipates it would have money to distribute to unsecured creditors, who get paid last.

Telescope Dreams-- PBS' Journey to Palomar

A seemingly typical moment in PBS' fascinating new documentary, "Journey to Palomar" comes about halfway through the film. George Ellery Hale, the American astronomer who is the subject of the documentary, is fresh off a nervous breakdown. He is recovering in Italy when he learns that one of the richest men in history just gave a sizable chunk of cash to help Hale realize his latest dream -- finishing the 100-inch Hooker telescope atop Mount Wilson near Pasadena, CA.

The nice cancer bloggers

Reaching for a box of cereal in the supermarket, I notice a woman a few feet away mulling over energy bars. She looks to be about my age: late 20's or early 30's. And she's bald - no eyelashes, no eyebrows, dressed in navy sweats. The nervous banter starts in my head.

YM Blog-a-Thon: Pre-Election Jitters

It’s funny, somewhere in the YO! archives there’s a blog written by yours truly around December 2007, or maybe January of this year, where I explain why I’m politically “apathetic”. Today, almost a year of campaigns and politics later, I’m at my wit’s end, on the edge of my seat in a nervous sweat, anything but apathetic about tomorrow’s election day.

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies

PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients accelerate and refine their therapeutic target discovery and validation efforts. Using our high resolution expression profiling analysis, we identify novel transcripts coding for new protein variants that may be involved in various genetic disorders such as oncology, central nervous system, or immune system disorders. This mouse SpliceArray(TM) products represent the achievement of more two years of work by our R&D team after the launch of the Human genome SpliceArray(TM) in 2007 and the rat genome SpliceArray(TM) earlier this year.

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies

PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients accelerate and refine their therapeutic target discovery and validation efforts. Using our high resolution expression profiling analysis, we identify novel transcripts coding for new protein variants that may be involved in various genetic disorders such as oncology, central nervous system, or immune system disorders. This mouse SpliceArray(TM) products represent the achievement of more two years of work by our R&D team after the launch of the Human genome SpliceArray(TM) in 2007 and the rat genome SpliceArray(TM) earlier this year.

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies

PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients accelerate and refine their therapeutic target discovery and validation efforts. Using our high resolution expression profiling analysis, we identify novel transcripts coding for new protein variants that may be involved in various genetic disorders such as oncology, central nervous system, or immune system disorders. This mouse SpliceArray(TM) products represent the achievement of more two years of work by our R&D team after the launch of the Human genome SpliceArray(TM) in 2007 and the rat genome SpliceArray(TM) earlier this year.

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human

PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients accelerate and refine their therapeutic target discovery and validation efforts. Using our high resolution expression profiling analysis, we identify novel transcripts coding for new protein variants that may be involved in various genetic disorders such as oncology, central nervous system, or immune system disorders. This mouse SpliceArray(TM) products represent the achievement of more two years of work by our R&D team after the launch of the Human genome SpliceArray(TM) in 2007 and the rat genome SpliceArray(TM) earlier this year.

Search took 0.02 seconds.